FDA grants accelerated approval to AstraZeneca's ovary cancer drug
December 19, 2014 at 12:32 PM EST
Dec 19 (Reuters) - AstraZeneca Plc's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after it was approved by the European Commission.